EMG Holdings’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding FSNB.WS
RCM
SCM
SIA
ETH
GAM
SBLIC
DCM
SMA
RCM
EMG Holdings's FSNB.WS Position: Q4 2022 in Review
EMG Holdings sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q4 2022, closing a stake of 16,666 shares — an estimated $1K sold.
EMG Holdings first reported a position in FSNB.WS in Q4 2021 and held it in 4 quarters. The position peaked at $10K in Q4 2021. 15 funds tracked by Wall St. Rank hold FSNB.WS as of Q4 2022.
- EMG Holdings reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- EMG Holdings sold 16,666 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $1K.
- EMG Holdings first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q4 2021 and held it in 4 quarters.
- EMG Holdings's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $10K in Q4 2021.
- 15 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q4 2022.
Based on EMG Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.